• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物受体在阿尔茨海默病性视神经病变中上调。

Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.

作者信息

Wang Michelle Y, Ross-Cisneros Fred N, Aggarwal Divya, Liang Chiao-Ying, Sadun Alfredo A

机构信息

Department of Ophthalmology, Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Acta Neuropathol. 2009 Sep;118(3):381-9. doi: 10.1007/s00401-009-0513-4. Epub 2009 Mar 11.

DOI:10.1007/s00401-009-0513-4
PMID:19277685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2867613/
Abstract

Although Alzheimer's disease (AD) has been shown to be associated with a true primary optic neuropathy, the underlying pathophysiology of this disease and in particular the optic nerve disorder is still poorly understood. The receptor for advanced glycation end products (RAGE) has been implicated in the pathogenesis of AD by mediating the transport of plasma amyloid-beta into the brain. Once ligated, RAGE can play a role in signal transduction, leading to amplification and perpetuation of inflammatory processes. As a key player in the reaction to CNS injury, astrocytes have been shown to associate with RAGE in a number of diseases, including AD. To investigate the role of RAGE and astrocytes in the pathogenesis of AD optic neuropathy, we conducted immunohistochemical studies to examine the presence of RAGE in donor eyes from patients with AD (n = 10) and controls (n = 3). Both qualitative observation and quantitative analyses using imaging software were used to document the extent of RAGE in the neural tissues. The intensity and extent of RAGE expression was more prominent in AD nerves compared to controls (P < 0.05). The RAGE immunoreactivity was observed in the microvasculature and in close proximity to astrocytic processes. While RAGE immunoreactivity increased with age, the increase was more precipitous in the AD group compared to the controls. The up-regulation of RAGE in the AD optic nerves indicates that RAGE may play a role in the pathophysiology of AD optic neuropathy.

摘要

尽管阿尔茨海默病(AD)已被证明与真正的原发性视神经病变有关,但这种疾病的潜在病理生理学,尤其是视神经疾病,仍知之甚少。晚期糖基化终产物受体(RAGE)通过介导血浆β淀粉样蛋白进入大脑,参与了AD的发病机制。一旦被连接,RAGE可在信号转导中发挥作用,导致炎症过程的放大和持续。作为中枢神经系统损伤反应的关键参与者,星形胶质细胞在包括AD在内的多种疾病中已被证明与RAGE有关。为了研究RAGE和星形胶质细胞在AD视神经病变发病机制中的作用,我们进行了免疫组织化学研究,以检查AD患者(n = 10)和对照组(n = 3)供体眼中RAGE的存在情况。使用成像软件进行定性观察和定量分析,以记录神经组织中RAGE的程度。与对照组相比,AD神经中RAGE表达的强度和程度更显著(P < 0.05)。在微血管和靠近星形胶质细胞突起处观察到RAGE免疫反应性。虽然RAGE免疫反应性随年龄增加,但与对照组相比,AD组的增加更为明显。AD视神经中RAGE的上调表明RAGE可能在AD视神经病变的病理生理学中起作用。

相似文献

1
Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.晚期糖基化终末产物受体在阿尔茨海默病性视神经病变中上调。
Acta Neuropathol. 2009 Sep;118(3):381-9. doi: 10.1007/s00401-009-0513-4. Epub 2009 Mar 11.
2
Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease.阿尔茨海默病性视神经病变中低密度脂蛋白受体相关蛋白减少。
J Neuroophthalmol. 2011 Jun;31(2):139-46. doi: 10.1097/WNO.0b013e31821b602c.
3
Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.晚期糖基化终末产物受体在阿尔茨海默病神经元和星形胶质细胞中的免疫组织化学分布
Brain Res. 2001 Jan 12;888(2):256-262. doi: 10.1016/s0006-8993(00)03075-4.
4
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.在阿尔茨海默病的三转基因小鼠模型中,神经元和星形胶质细胞中晚期糖基化终产物受体的表达增加。
Exp Mol Med. 2014 Feb 7;46(2):e75. doi: 10.1038/emm.2013.147.
5
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.早期和晚期阿尔茨海默病中海马区的晚期糖基化终末产物受体免疫反应性
Brain Res. 2008 Sep 16;1230:273-80. doi: 10.1016/j.brainres.2008.06.124. Epub 2008 Jul 14.
6
Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head.青光眼的加速衰老:人视网膜和视神经乳头中晚期糖基化终末产物的免疫组织化学评估
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1201-11. doi: 10.1167/iovs.06-0737.
7
Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.Aβ₁₋₄₂- RAGE 相互作用通过 Ca²⁺-钙调神经磷酸酶信号破坏血脑屏障的紧密连接。
J Neurosci. 2012 Jun 27;32(26):8845-54. doi: 10.1523/JNEUROSCI.6102-11.2012.
8
Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.异质性核糖核蛋白A1和Tra2β-1对晚期糖基化终末产物受体剪接的调控及其在阿尔茨海默病发病机制中的潜在作用。
J Neurochem. 2015 Apr;133(2):187-98. doi: 10.1111/jnc.13069. Epub 2015 Mar 2.
9
Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.阿尔茨海默病大脑海马神经元中晚期糖基化终产物内源性分泌受体的表达降低。
Arch Histol Cytol. 2007 Dec;70(5):279-90. doi: 10.1679/aohc.70.279.
10
Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.预防阿尔茨海默病中晚期糖基化终产物受体的激活。
Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210.

引用本文的文献

1
Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-β deposition.基于二氧化铈纳米团簇的阿尔茨海默病治疗:通过调节活化的小胶质细胞和减轻淀粉样β蛋白沉积
Cell Biomater. 2025 Aug 6. doi: 10.1016/j.celbio.2025.100158.
2
Toxic Advanced Glycation End-Products Inhibit Axonal Elongation Mediated by β-Tubulin Aggregation in Mice Optic Nerves.毒性晚期糖基化终产物通过β-微管蛋白聚集抑制小鼠视神经轴突伸长。
Int J Mol Sci. 2024 Jul 5;25(13):7409. doi: 10.3390/ijms25137409.
3
AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway.AGEs 通过 RAGE/NF-κB/Caveolin-1 通路增加 LDL 穿越内皮细胞,从而促进动脉粥样硬化。
Mol Med. 2023 Aug 21;29(1):113. doi: 10.1186/s10020-023-00715-5.
4
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.晚期糖基化终产物受体(RAGE):针对神经退行性疾病治疗的有前途的靶点。
Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.
5
Role of RAGE in the Pathogenesis of Neurological Disorders.晚期糖基化终产物受体(RAGE)在神经退行性疾病发病机制中的作用。
Neurosci Bull. 2022 Oct;38(10):1248-1262. doi: 10.1007/s12264-022-00878-x. Epub 2022 Jun 21.
6
The Beneficial Role of Exercise on Treating Alzheimer's Disease by Inhibiting β-Amyloid Peptide.运动通过抑制β-淀粉样肽在治疗阿尔茨海默病中的有益作用。
Mol Neurobiol. 2021 Nov;58(11):5890-5906. doi: 10.1007/s12035-021-02514-7. Epub 2021 Aug 20.
7
Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease.系统回顾人类死后免疫组化研究和生物信息学分析揭示了阿尔茨海默病中天 细胞反应的复杂性。
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12753. doi: 10.1111/nan.12753. Epub 2021 Aug 17.
8
Progress of RAGE Molecular Imaging in Alzheimer's Disease.阿尔茨海默病中晚期糖基化终末产物受体分子成像的研究进展
Front Aging Neurosci. 2020 Aug 4;12:227. doi: 10.3389/fnagi.2020.00227. eCollection 2020.
9
Too sweet: Problems of protein glycation in the eye.太甜了:眼睛中蛋白质糖化的问题。
Exp Eye Res. 2019 Jan;178:255-262. doi: 10.1016/j.exer.2018.08.017. Epub 2018 Aug 24.
10
One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.一种蛋白质,多种病理状态:淀粉样β蛋白在大脑和视网膜神经退行性疾病中的多方面作用。
Cell Mol Life Sci. 2016 Nov;73(22):4279-4297. doi: 10.1007/s00018-016-2295-x. Epub 2016 Jun 22.

本文引用的文献

1
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.早期和晚期阿尔茨海默病中海马区的晚期糖基化终末产物受体免疫反应性
Brain Res. 2008 Sep 16;1230:273-80. doi: 10.1016/j.brainres.2008.06.124. Epub 2008 Jul 14.
2
Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia.缺氧诱导因子-1介导缺氧/缺血后晚期糖基化终产物受体的神经元表达。
J Biol Chem. 2007 Dec 14;282(50):36330-40. doi: 10.1074/jbc.M706407200. Epub 2007 Oct 17.
3
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.使用石蜡切片和免疫细胞化学对阿尔茨海默病相关神经原纤维病变进行分期。
Acta Neuropathol. 2006 Oct;112(4):389-404. doi: 10.1007/s00401-006-0127-z. Epub 2006 Aug 12.
4
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.阿尔茨海默病中的晚期糖基化终末产物受体、低密度脂蛋白受体相关蛋白1及β-淀粉样蛋白
Acta Neuropathol. 2006 Oct;112(4):405-15. doi: 10.1007/s00401-006-0115-3. Epub 2006 Jul 25.
5
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.阿尔茨海默病和血管性痴呆中晚期糖基化终末产物可溶性受体的循环水平。
Arch Neurol. 2005 Nov;62(11):1734-6. doi: 10.1001/archneur.62.11.1734.
6
Understanding RAGE, the receptor for advanced glycation end products.了解晚期糖基化终产物受体(RAGE)。
J Mol Med (Berl). 2005 Nov;83(11):876-86. doi: 10.1007/s00109-005-0688-7. Epub 2005 Aug 24.
7
Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).通过晚期糖基化终产物受体(RAGE)起作用的β-淀粉样肽可重现阿尔茨海默病神经元胞质杂种细胞内信号改变和活力降低的情况。
Mol Cell Neurosci. 2005 Jun;29(2):333-43. doi: 10.1016/j.mcn.2005.02.012.
8
Neurovascular mechanisms of Alzheimer's neurodegeneration.阿尔茨海默病神经退行性变的神经血管机制。
Trends Neurosci. 2005 Apr;28(4):202-8. doi: 10.1016/j.tins.2005.02.001.
9
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.晚期糖基化终末产物与受体(RAGE):衰老、糖尿病、神经退行性变及炎症中的共同线索
Glycobiology. 2005 Jul;15(7):16R-28R. doi: 10.1093/glycob/cwi053. Epub 2005 Mar 10.
10
RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.晚期糖基化终末产物受体(RAGE)增强了转基因小鼠中β-淀粉样蛋白(Aβ)诱导的神经元功能紊乱。
EMBO J. 2004 Oct 13;23(20):4096-105. doi: 10.1038/sj.emboj.7600415. Epub 2004 Sep 30.